Login to Your Account



Oxford BioTherapeutics Looks to Switzerland for Clinical Work

By Cormac Sheridan
Staff Writer

Wednesday, May 9, 2012
The steady maturation of several preclinical development programs has prompted Oxford BioTherapeutics Ltd. to establish a clinical development unit, which it is locating in Basel, Switzerland.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription